RxDoctor Payments Data

Jason Chin, OD

Optometrist · Boston, MANPI 1184624082

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 25.4% of the total. 2025 is the largest year on record at $285, 7.7 times the $37 reported in 2019.

$959in general payments, 2019–2025

Across 30 payments — averaging $31.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$243
  • Dompe US, Inc.$134
  • Oyster Point Pharma, Inc.$125
  • Alcon$99
  • Amgen$98
  • Johnson & Johnson Vision Care, Inc.$90
  • plus $171 from 4 others
$609,334in research payments, 2019–2025

Across 31 payments — averaging $19,656 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Alcon Research LLC$516K
  • Oyster Point Pharma, Inc.$68K
  • Nidek CO., LTD.$26K

What the payments were for

  • Food & beverage$959100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$959 in reported general payments places this provider in the 65th percentile of 1,084 optometrist providers in Massachusetts.

See all optometrist providers in Massachusetts

Medicare billing

Part B allowed, 2024
$17,602
Medicare patients
129
Services billed
170

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other optometrist in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →